APEL

GERMAGIC(TM) PET Hosts "Social Inclusion Charity Run with Pets"

Retrieved on: 
Monday, March 18, 2024
Yee, Health, New Territories, Social, Certification, Social exclusion, Pet, Environment, Companion, City University, Business, PET, Life, SGS, Bacteria, Virus, APEL, Athlete, Human, Dog, Biochemistry, Love, QPP, Safety, Metro Broadcast Corporation, Cat, Creative industries

GERMAGIC(TM) PET is the title sponsor of the "Social Inclusion Charity Run with Pets" on 17 March.

Key Points: 
  • GERMAGIC(TM) PET is the title sponsor of the "Social Inclusion Charity Run with Pets" on 17 March.
  • To provide pets with more care and protection, GERMAGIC(TM) PET continuously innovates and utilizes its scientific research technology to develop various green pet health products, thus promoting social inclusion and sustainable development.
  • GERMAGIC(TM) PET products utilize GERMAGIC(TM)'s encapsulation technology and molecular materials to comprehensively support and protect pet health.
  • This certification not only recognizes the quality of GERMAGIC(TM) PET products but also sets higher quality standards for the pet health industry.

APEL Biomedical Technology Innovation and Translational Commercial Laboratory Officially Opens

Retrieved on: 
Wednesday, March 13, 2024
Yee, New Territories, Nutrition, Health, Technology transfer, Quality of life, HKSAR, Hygiene, QPP, Corporation, Certification, Environment, Innovation, Biotechnology, Partnership, Biomedical technology, Biological engineering, Translational research, Silk, Knowledge, Research, SGS, Lifestar, Translation, Science park, Sustainability, Pet, Government, Growth, Greater, Perception, PET, HKSTP, APEL, Life, Hong Kong Science Park, Toxicology, Division, Medical imaging

Dr. Grace Lau, Head of Institute for Translational Research of Hong Kong Science and Technology Parks Corporation (HKSTP) stated, "It is great to see the official opening of APEL Laboratory and the successful transformation of scientific research and technology into commercial products.

Key Points: 
  • Dr. Grace Lau, Head of Institute for Translational Research of Hong Kong Science and Technology Parks Corporation (HKSTP) stated, "It is great to see the official opening of APEL Laboratory and the successful transformation of scientific research and technology into commercial products.
  • We have attracted numerous biomedical innovation and technology enterprises, covering areas such as pharmaceuticals, medical devices, diagnostics, and traditional Chinese medicine.
  • Today, we are delighted to have officially established our presence in Hong Kong Science Park with the opening of the Biomedical Technology Innovation and Translational Commercial Laboratory.
  • The pet industry ecosystem is vibrant, and today, during the inauguration ceremony of the APEL Biomedical Technology Innovation and Translational Commercial Laboratory, APEL also organized a panel discussion on the future opportunities and transformations in the pet industry.

Artisan Partners Launches Artisan Emerging Markets Local Opportunities Strategy

Retrieved on: 
Wednesday, July 20, 2022
Time-invariant system, APLP, U.S. Securities and Exchange Commission, APEL, SEC, Compliance, Central Bank of Ireland, Risk, Instability, News, Financial Conduct Authority, Review, Method, Loss, Investment, International, Central bank, Security (finance)

Artisan Partners Limited Partnership (APLP) is an investment adviser registered with the U.S. Securities and Exchange Commission (SEC).

Key Points: 
  • Artisan Partners Limited Partnership (APLP) is an investment adviser registered with the U.S. Securities and Exchange Commission (SEC).
  • Artisan Partners UK LLP (APUK) is authorized and regulated by the Financial Conduct Authority and is a registered investment adviser with the SEC.
  • APLP, APUK and AP Europe are collectively, with their parent company and affiliates, referred to as Artisan Partners herein.
  • These risks typically are greater in emerging and less developed markets, including frontier markets.

Align Capital Partners Announces Sale of Pleatco Filtration to Pentair plc

Retrieved on: 
Wednesday, September 15, 2021
Professional Services, Engineering, Other Professional Services, Manufacturing, Finance, Other Manufacturing, TVS, Filtration, Pentair, Investment, EFI, Technology, Marketing, Company, CFO, McGuireWoods, CRO, ACP, APriori Capital Partners, NYSE, Industry, Environment, Growth, Senior, PNR, Partnership, APEL, Acquisition, MRO, Bottled water, Security (finance)

Align Capital Partners (ACP) announces that its portfolio company Pleatco Filtration (Pleatco or the Company) has entered into a definitive agreement to be acquired by Pentair plc (Pentair) (NYSE: PNR) for $255 million.

Key Points: 
  • Align Capital Partners (ACP) announces that its portfolio company Pleatco Filtration (Pleatco or the Company) has entered into a definitive agreement to be acquired by Pentair plc (Pentair) (NYSE: PNR) for $255 million.
  • During the partnership, Pleatco more than doubled its revenue and increased employee headcount from 180 to more than 380.
  • ACPs operating and growth resources served as active partners who committed much more than just capital to our management team.
  • Align Capital Partners is a growth-oriented private equity firm that partners with business owners and management teams to create shared success.

Pentair Announces Definitive Agreement to Acquire Pleatco

Retrieved on: 
Wednesday, September 15, 2021
Other Energy, Environment, Other Construction & Property, Manufacturing, Energy, Construction & Property, Other Manufacturing, Risk, OH, Hart–Scott–Rodino Antitrust Improvements Act, TVS, U.S. Securities and Exchange Commission, Water, Filtration, Security (finance), EFI, CEO, Vaccination, Marketing, Weather, Private Securities Litigation Reform Act, Stauch, Total, NYSE, Annual report, Industry, Environment, Solution, COVID-19, PNR, APEL, Acquisition, Life, Risk management

Pentair plc (NYSE: PNR), a leading provider of water treatment and sustainable solutions, today announced that it has entered into a definitive agreement to acquire Pleatco, a manufacturer of water filtration and clean air technologies for pool, spa and industrial air customers.

Key Points: 
  • Pentair plc (NYSE: PNR), a leading provider of water treatment and sustainable solutions, today announced that it has entered into a definitive agreement to acquire Pleatco, a manufacturer of water filtration and clean air technologies for pool, spa and industrial air customers.
  • Pleatco is a current portfolio company of Align Capital Partners, a private equity firm with investment teams in Dallas, TX and Cleveland, OH.
  • We look forward to welcoming the Pleatco employees to Pentair and to growing the relationship with Pleatcos existing customer base, continued Stauch.
  • Pentair expects Pleatco to generate approximately $95 million of annual revenue in 2021.